{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":3,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":55,"n_cols":5,"rows_kept":55,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[11,2,11,3],[12,2,12,3],[16,2,16,3],[19,2,19,3],[19,4,19,5],[20,2,20,3],[20,4,20,5],[21,2,21,3],[21,4,21,5],[22,2,22,3],[24,2,24,3],[26,2,26,3],[27,2,27,3],[28,2,28,3],[29,2,29,3],[30,2,30,3],[31,2,31,3],[33,2,33,3],[42,2,42,3],[42,4,42,5],[43,2,43,3],[43,4,43,5],[44,2,44,3],[44,4,44,5],[45,2,45,3],[46,2,46,3],[47,2,47,3],[48,2,48,3],[52,2,52,3],[53,2,53,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910461149803321"]
[null,null,"Autore",null,"Schmidt Edyta"]
[null,null,"Titolo",null,"Lernen nach montessori im spiegel der neurowissenschaften : Lassen sich die Annahmen und Prinzipien der Pädagogik Maria Montessoris durch neurowissenschaftliche Erkenntnisse zum themenbereich Lernen bestätigen? / / Edyta Schmidt"]
[null,null,"Pubbl/distr/stampa",null,"Hamburg, [Germany] : , : Diplomica Verlag, , 2015"]
[{"$nulls":4},"©2015"]
[null,null,"ISBN",null,"3-8428-3285-0"]
[null,null,"Descrizione fisica",null,"1 online resource (112 p.)"]
[null,null,"Disciplina",null,"371.392"]
[null,null,"Soggetti",null,"Montessori method of education"]
[{"$nulls":4},"Education, Preschool - Philosophy"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Tedesco"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"1 THEMATIK, WEGE DER BEARBEITUNG UND DARSTELLUNG ; 1.1 Thematik ; 1.2 Voraussetzungen in Literatur und Forschung, Verbreitung und  Rezeption; 1.3 Wege der Bearbeitung und Darstellung ; 2 DIE MONTESSORI- PÄDAGOGIK; 2.1 Leben der Maria Montessori; 2.2 Das pädagogische Konzept; 3 DIE NEUROWISSENSCHAFTEN; 3.1 Gegenstand und aktuelle Entwicklungen; 3.2 Methoden  ; 3.3 Probleme und Grenzen neurowissenschaftlicher Forschung; 3.4 Das Verhältnis von Neurowissenschaften und Pädagogik ; 3.5 Der Lernbegriff"]
[{"$nulls":4},"6.3 Ergebnisse der Untersuchung der Bedingungen des Lernens Literaturangaben"]
[null,null,null,"Sommario/riassunto","Maria Montessoris reformpädagogischer Ansatz gehört unbestritten zu den pädagogischen Klassikern. Er bezeichnet eine ab 1906 entwickelte Bildungsmethodik und -philosophie für Kindergärten und Schulen und genießt auch heute noch eine beträchtliche Relevanz. Die Ergebnisse der Neurowissenschaften hingegen drängen erst seit den letzten Jahren zunehmend in die pädagogische Fachöffentlichkeit und Theorieentwicklung, da ihnen technische Fortschritte Möglichkeiten eröffneten, Aussagen zu Bedingungen des Lernens zu treffen. Montessori erstellte ihr didaktisches Konzept aufgrund von Beobachtungen und E"]
[null,"2.","Record Nr.",null,"UNINA9910585799403321"]
[null,null,"Autore",null,"Simon Toby L"]
[null,null,"Titolo",null,"Rossi's principles of transfusion medicine"]
[null,null,"Pubbl/distr/stampa",null,"Newark : , : John Wiley & Sons, Incorporated, , 2022"]
[{"$nulls":4},"©2022"]
[null,null,"ISBN",null,"1-119-71980-1"]
[{"$nulls":4},"1-119-71978-X"]
[null,null,"Edizione",null,"[6th ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (733 pages)"]
[null,null,"Disciplina",null,"615.3/9"]
[null,null,"Soggetti",null,"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,"Nota di contenuto",null,"Cover -- Title Page -- Copyright Page -- Contents -- List of contributors -- Preface -- List of abbreviations -- About the companion website -- SECTION I Transfusion medicine from ancient times to the current pandemic -- CHAPTER 1 Transfusion in the new millennium -- The first animal transfusion -- The first animal-to-human transfusion -- The beginnings of modern transfusion -- The twentieth century -- Anticoagulants, the blood bank, and component therapy -- Transfusion in the age of technology -- Concern for blood safety -- Current status -- Organization of blood services in the United States -- Organization of blood services outside the United States -- Disclaimer -- Key references -- CHAPTER 2 Disasters and the blood community (including COVID-19) -- Background -- Organization for emergency operations -- Planning for blood and transfusion in disasters -- Continuity of operations plans -- Regulatory considerations in disasters -- National authority -- Determination of the acceptability of components in available inventory -- Potential consequences on operations -- Records management -- The COVID-19 pandemic and transfusion medicine -- Key references -- CHAPTER 3 Responding to regulatory challenges during public health emergencies -- Connection between public health emergencies and blood transfusion -- Approach to pandemic management -- Epidemiologic surveillance -- Diagnostic testing -- Containment and mitigation -- Therapeutics and vaccines -- Case study of a therapeutic: COVID-19 convalescent plasma -- Summary -- Key references -- SECTION II Blood donation -- CHAPTER 4 Recruitment "]
[{"$nulls":4},"and screening of donors and the collection of blood -- Donor demographics -- Donor recruitment and retention -- Theories of donation behavior -- Donor retention and repeated donations -- Extraordinary donations following disasters."]
[{"$nulls":4},"Recipient-specific blood donation -- Autologous donations -- Directed donations -- Exceptional medical need -- The collection process for blood components for transfusion: screening, informed consent, phlebotomy, collection, and postdonation -- Donor screening -- The current DHQ -- Changes to the current DHQ based on history of MSM -- Changes to the FDA required deferrals for risk of CJD and vCJD -- Educational materials and informed consent -- Method of administration -- Vital sign measurement -- Blood collection -- Whole blood -- Postdonation care -- Component separation -- Apheresis Collection -- The collection process for source plasma: screening, phlebotomy, choice of product, collection, and testing of source plasma donors -- Blood collection changes with patient needs -- Key references -- CHAPTER 5 Blood donor testing -- Background -- Safety of the blood supply -- Blood component testing -- ABO typing -- Rh typing -- Red blood cell antibody detection -- ABO antibody titers -- Direct antiglobulin testing -- Testing for transmissible diseases -- General concepts of infectious disease testing -- Testing in resource-limited settings -- Plasma for further manufacture: source plasma -- Donor management -- Product management -- Retrieval of in-date products and recipient notification -- Donor Re-entry -- HIV testing -- HIV antibody testing -- HIV NAT -- HIV confirmatory testing -- Hepatitis B testing -- Hepatitis B surface antigen -- Anti-HBc antibody -- HBV NAT -- Hepatitis C testing -- HCV antibody screening -- HCV NAT donor screening -- Human T-cell lymphotropic virus testing -- West Nile virus testing -- Zika virus testing -- Testing for babesiosis -- Syphilis testing -- Treponema pallidum: T. pallidum and non-T. pallidum testing -- Chagas' disease testing -- CMV testing -- Additional testing for blood derivatives."]
[{"$nulls":4},"Bacterial testing of platelets -- Other laboratory testing -- HLA antibody testing -- Extended blood group antigen typing -- Role of platelet antigen typing -- Role of platelet serology -- Parvovirus B19 and hepatitis A virus testing -- Hemoglobin S testing -- Screening donors for IgA deficiency -- Summary -- Key references -- CHAPTER 6 Acute adverse reactions after blood donation -- Adverse reactions after blood donation -- Acute reactions after blood donation: immediate symptoms and delayed complications -- Risk factors associated with reactions after blood donation -- Preventing syncopal reactions at blood drives -- Phlebotomy-related complications -- Phlebotomy-related nerve injury -- Reactions after automated collection of cellular blood components -- Citrate reactions and other immediate complications during apheresis procedures -- Procedure-related complications related to donation frequency or multiple component collection -- Special considerations: granulocyte collection -- Conclusion -- Key references -- CHAPTER 7 Chronic effects of blood and plasma donation -- Introduction -- Prevalence of and risk factors for iron depletion in blood donors -- Regulatory considerations: Role of the Food and Drug Administration and AABB -- Adverse outcomes potentially associated with iron depletion -- Potentially vulnerable populations -- Potential measures for mitigation of iron depletion -- Long-term issues for platelet donors -- Long-term issues for source plasma donors -- Summary -- Key references -- CHAPTER 8 Global perspective: ensuring blood and blood product safety and availability through regulation and certification -- US perspective on ensuring blood and blood product safety and availability -- History of safety "]
[{"$nulls":4},"and efficacy requirements for drugs and biologics in the United States -- FDA regulation of blood collection establishments."]
[{"$nulls":4},"Regulation and accreditation of hospital transfusion services -- International perspective on ensuring blood and blood product safety and availability -- WHO programs for blood and blood component transfusion safety -- Regulation of and guidance on blood products in Europe -- The European Union and associated organizations -- Council of Europe and associated organizations -- Authorization in Europe of plasma derivative and analogous recombinant products -- Safety monitoring of medicines in Europe -- Activities to promote blood component safety in Europe -- Other major international organizations involved in the regulation or standardization of blood, blood products, and their biotechnology analogs -- FDA role in the global regulation of blood and blood products -- Acknowledgement -- Key references -- SECTION III Blood groups and pretransfusion testing -- CHAPTER 9 Carbohydrate blood groups -- ABO system -- Chemistry and biosynthesis -- ABH antibodies -- Serology of the ABO system -- Molecular biology -- Transfusion and transplantation -- Biological role -- Lewis blood group -- Serology -- Synthesis and biochemistry -- Molecular biology of Lewis and secretor genes -- Blood transfusion and transplantation -- Biological roles -- I blood group -- I/i expression -- Biochemistry -- Molecular biology and genetics -- Transfusion -- Biological roles -- P blood group system -- Biochemistry and synthesis -- Serology -- Genetics and molecular biology -- Transfusion medicine -- Biological role -- Sda (SID) -- Serology and transfusion -- Biochemistry and synthesis -- Molecular biology -- Biological role -- Key references -- CHAPTER 10 Rh and LW blood group antigens -- Summary -- Rh blood group system -- History and nomenclature -- Genes and their expressed proteins -- Association with RhAG -- Basis for antigen expression -- Rh membrane complex and Rhnull phenotype."]
[{"$nulls":4},"Rh family and function -- Immune response to Rh -- LW blood group system -- History and nomenclature -- Genes and their expressed proteins -- Basis for antigen expression -- LW function -- Summary -- Key references -- CHAPTER 11 Other protein blood groups -- MNS blood group system (ISBT 002) -- MNS in transfusion medicine -- Lutheran blood group system (ISBT 005) -- Kell and Kx blood group systems (ISBT 006 and 019) -- Structure, function, and interaction of the Kell and XK proteins -- Kell in transfusion medicine -- Null phenotypes -- Duffy blood group system (ISBT 008) -- Structure and function of the Duffy protein -- Duffy in transfusion medicine -- Kidd blood group system (ISBT 009) -- Diego blood group system (ISBT 010) -- Structure and function of the Diego protein -- Diego in transfusion medicine -- Xg blood group system (ISBT 012) -- Scianna blood group system (ISBT 013) -- Colton and GIL blood group systems (ISBT 015 and 029) -- Chido/Rodgers blood group system (ISBT 017) -- Gerbich blood group system (ISBT 020) -- Knops blood group system (ISBT 022) -- Indian blood group system (ISBT 023) -- Blood group antigens on glycosylphosphatidylinositol-linked proteins: Cartwright (ISBT 011), Dombrock (ISBT 014), Cromer (ISBT 021), JMH (ISBT 026), CD59 (ISBT 035), KANNO (ISBT 037), and EMM (ISBT 042) -- Other minor blood group systems: OK (ISBT 024), RAPH (ISBT 025), JR (ISBT 032), LAN (ISBT 033), VEL (ISBT 034), AUG (ISBT 036), CTL2 (ISBT 039), PEL (ISBT 040), MAM (ISBT 041), and ABCC1 (ISBT 043) -- Summary -- Disclaimer -- Key references -- CHAPTER 12 Immunohematology and compatibility testing -- Introduction -- Red cell immunology -- The basics of the immune response -- Antigen receptors on T cells and B cells -- Immunoglobulin molecules -- "]
[{"$nulls":4},"Exposure to foreign protein antigens -- Blood group antibodies -- Red cell antigen-antibody interactions."]
[{"$nulls":4},"Compatibility testing."]
[null,"3.","Record Nr.",null,"UNINA990003348040403321"]
[null,null,"Autore",null,"Alemán, Mateo <1547-1615>"]
[null,null,"Titolo",null,"Guzman de Alfarache / Mateo Aleman ; edicion y notas de Samuel Gili y Gaya"]
[null,null,"Pubbl/distr/stampa",null,"Madrid, : Espasa-Calpe, 1926/27"]
[null,null,"Disciplina",null,"863"]
[null,null,"Locazione",null,"DECLI"]
[null,null,"Collocazione",null,"863 ALE /4"]
[{"$nulls":4},"863 ALE /5"]
[{"$nulls":4},"863 ALE /6"]
[{"$nulls":4},"863 ALE /7"]
[null,null,"Lingua di pubblicazione",null,"Spagnolo"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]